title: WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-ninth report.
abstract: The Expert Committee on Specifications for Pharmaceutical Preparations works towards clear, independent and practical standards and guidelines for the quality assurance of medicines. Standards are developed by the Committee through worldwide consultation and an international consensus-building process. The following new guidelines were adopted and recommended for use. Revised procedure for the development of monographs and other texts for The International Pharmacopoeia; Revised updating mechanism for the section on radiopharmaceuticals in The International Pharmacopoeia; Revision of the supplementary guidelines on good manufacturing practices: validation, Appendix 7: non-sterile process validation; General guidance for inspectors on hold-time studies; 16 technical supplements to Model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products; Recommendations for quality requirements when plant-derived artemisinin is used as a starting material in the production of antimalarial active pharmaceutical ingredients; Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability: revision; Guidance on the selection of comparator pharmaceutical products for equivalence assessment of interchangeable multisource (generic) products: revision; and Good review practices: guidelines for national and regional regulatory authorities.
mesh_terms: D004345:Drug Industry / Q000592:standards*; D004355:Drug Stability; D004356:Drug Storage; D016568:Drugs, Generic / Q000592:standards; D017408:Guidelines as Topic; D006801:Humans; D004364:Pharmaceutical Preparations / Q000737:chemistry / Q000592:standards*; D011786:Quality Control; D013696:Temperature; D013997:Time Factors; D014186:Transportation; D014944:World Health Organization
chemical_list: D016568:Drugs, Generic; D004364:Pharmaceutical Preparations